- Home
- IMNM vs MERC Comparison
IMNM vs MERC Comparison
Compare IMNM & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- MERC
- Stock Information
- Founded
- IMNM 2006
- MERC 1968
- Country
- IMNM United States
- MERC Canada
- Employees
- IMNM N/A
- MERC N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- MERC Paper
- Sector
- IMNM Health Care
- MERC Basic Materials
- Exchange
- IMNM Nasdaq
- MERC Nasdaq
- Market Cap
- IMNM 542.6M
- MERC 468.8M
- IPO Year
- IMNM 2020
- MERC 1987
- Fundamental
- Price
- IMNM $7.91
- MERC $4.96
- Analyst Decision
- IMNM Strong Buy
- MERC Hold
- Analyst Count
- IMNM 6
- MERC 2
- Target Price
- IMNM $26.00
- MERC $7.75
- AVG Volume (30 Days)
- IMNM 1.7M
- MERC 444.2K
- Earning Date
- IMNM 05-13-2025
- MERC 05-01-2025
- Dividend Yield
- IMNM N/A
- MERC 6.05%
- EPS Growth
- IMNM N/A
- MERC N/A
- EPS
- IMNM N/A
- MERC N/A
- Revenue
- IMNM $9,041,000.00
- MERC $2,043,360,000.00
- Revenue This Year
- IMNM N/A
- MERC $3.26
- Revenue Next Year
- IMNM $1,259.12
- MERC $5.78
- P/E Ratio
- IMNM N/A
- MERC N/A
- Revenue Growth
- IMNM N/A
- MERC 2.48
- 52 Week Low
- IMNM $5.15
- MERC $4.74
- 52 Week High
- IMNM $19.07
- MERC $11.20
- Technical
- Relative Strength Index (RSI)
- IMNM 55.28
- MERC 32.24
- Support Level
- IMNM $6.96
- MERC $4.74
- Resistance Level
- IMNM $7.56
- MERC $5.22
- Average True Range (ATR)
- IMNM 0.69
- MERC 0.38
- MACD
- IMNM 0.26
- MERC -0.02
- Stochastic Oscillator
- IMNM 98.22
- MERC 15.28
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.